展区概况 Bio-based 2026生物基展览 将继续招募全品类产业上下游创新产品，包括 生物基化学品、生物基塑料与制品、生物基纺织与鞋服、生物基橡胶、仪 器与设备、第三方检测与认证、工程技术与EPC、政府与园区、投资 等 。 展区内另设终端品牌需求对接专场；生物基材料标准评审会；新产品新技术发布会；生物基产业高层战略研讨会（第9期）以及11场主题论坛等 主办 方独家策划活动 。 与此同时， 第四届新叶奖（NEW LEAF AWARD 2026）创新评选颁奖 仪式将同期进行，展会以更持续、更多元、更接近行业需 求，为大家带来更多新生机。 02 展览观众类型 行业中高层聚集 Bio-based 2026生物基展览 的参 会观展规模预计超 过 1500人 。观众覆 盖生物基产品全产业链上、中、下游参与者，企业中高管、决策者、研发 人、终端用户材料负责人等。 Bio-based 生物基展 是生物基大会同期举办的生物基产业上下游专业展览。展览聚焦创新和全产业链，为生物基企业提供专业优质的展示交流平台， 推动行业发展。 Bio-based 2026生物基展览正式官宣！ Bio-based 2026生物基展由浙江省全省 ...

Core Viewpoint - 九州通 has successfully completed the restructuring investment plan for Aoyuan Meigu, acquiring its core assets for 706 million yuan, marking a strategic entry into the medical beauty sector [1][2][4] Group 1: Company Overview - Aoyuan Meigu, established in 1993 and formerly known as Hubei Jinhui, transitioned into the medical beauty industry after being acquired by Aoyuan Group in 2020 [2] - The company primarily focuses on bio-based fibers and medical beauty services, operating two high-end medical beauty hospitals with over 330,000 members and 80,000 active members annually [2] - In 2024, Aoyuan Meigu's medical beauty business is projected to generate 624 million yuan in revenue, accounting for 57% of total revenue [2] Group 2: Financial and Operational Challenges - Aoyuan Meigu has faced continuous operating losses and a debt crisis, leading to its stock being marked with "delisting risk warning" in 2023 [2] - The company was unable to repay due debts, prompting creditors to apply for restructuring in November 2024, which was approved by the court in December [3][4] Group 3: Strategic Implications for 九州通 - 九州通, as a leading private pharmaceutical distribution company, has built a comprehensive supply chain service platform and has been involved in the medical beauty sector for over 10 years [5][6] - The acquisition of Aoyuan Meigu allows 九州通 to establish a full-chain layout from upstream procurement to downstream service terminals, enhancing its competitive edge [6][7] - The domestic medical beauty market has surpassed 300 billion yuan, with an annual growth rate exceeding 18%, presenting significant opportunities for 九州通 to leverage its supply chain and improve profitability [6][7]

Core Viewpoint - The textile industry in China is undergoing a green transformation driven by the launch of a new research project focused on bio-based fibers, aligning with national carbon neutrality goals and addressing industry challenges [1][2]. Group 1: Project Overview - The project aims to develop a new evaluation system for bio-based fibers, addressing issues such as performance instability and high production costs, which are approximately 30% higher than traditional fibers [1]. - The initiative is part of the "Textile Industry Quality Improvement Implementation Plan (2023-2025)" issued by multiple government departments, emphasizing the need for a low-carbon transition in the textile sector [1]. Group 2: Technological Innovations - The project will enhance the strength of bio-based fibers to match that of fossil-based fibers through molecular design optimization and improved processing techniques, potentially reducing production costs by over 20% [2]. - It will also establish performance evaluation standards for bio-based fibers and carbon footprint accounting, filling a significant gap in domestic standards and aligning with international regulations [2]. Group 3: Collaborative Model - The project will integrate resources from over 20 research institutions and 30 key enterprises, forming a collaborative network of monitoring agencies, universities, leading companies, and downstream application sectors to accelerate technology transfer [2]. Group 4: Expected Outcomes - The application of project results is expected to significantly reduce carbon emissions in the textile industry by over 10 million tons annually and drive the growth of the bio-based fiber industry by over 50 billion [2]. - The project will facilitate the upgrade of traditional textile products towards low-carbon and environmentally friendly options, meeting the growing consumer demand for sustainable products [2]. Group 5: Future Plans - The project is set to complete core technology development and standard system construction within two years, with plans to initiate over 10 large-scale application demonstration projects across various sectors [3]. - This initiative marks a new phase in the development of China's bio-based fiber industry, contributing to global sustainable textile development [3].

Group 1 - The core point of the article is that *ST Meigu (SZ 000615) held its 27th meeting of the 11th Board of Directors on November 5, 2025, to discuss the proposal for the third extraordinary shareholders' meeting in 2025 [1] - For the first half of 2025, *ST Meigu's revenue composition is as follows: medical beauty services accounted for 57.47%, bio-based fibers accounted for 38.54%, and others accounted for 3.99% [1] - As of the report date, *ST Meigu has a market capitalization of 3 billion yuan [1]

Core Viewpoint - The article highlights the innovative "Three-Component Separation Technology" developed by Zhongnong Qimei, which transforms agricultural waste (straw) into high-value industrial products, addressing both resource utilization and environmental protection challenges in China [3][6][10]. Group 1: Technology Overview - Zhongnong Qimei's "Three-Component Separation Technology" was showcased at the 32nd China Yangling Agricultural High-Tech Achievements Expo, gaining significant attention [3][5]. - This technology allows for the complete decomposition of straw from nine major crops, converting it into pulp fibers, lyocell fibers, and soluble humic acid, achieving zero waste and low energy consumption [6][9]. - The technology integrates enzyme preparation, AI-enabled equipment systems, and smart process reconstruction, resulting in a 70% reduction in energy consumption and an 80% decrease in water usage [7][9]. Group 2: Market Potential and Trends - The annual collection of straw in China reaches 737 million tons, and the government supports the comprehensive utilization of straw as outlined in the 2025 Central Document No. 1 [5][10]. - The agricultural biotechnology sector is experiencing rapid growth, with synthetic biology projects receiving significant investment, indicating market recognition and capital interest [10][11]. - Zhongnong Qimei's dual-core product system of "bio-based fibers + humic acid" addresses the inefficiencies in straw utilization and opens new market opportunities, particularly in the paper industry [10][11]. Group 3: Strategic Collaborations and Future Plans - Strategic partnerships have been established with several companies, marking a transition from initial technology development to large-scale replication [13]. - Zhongnong Qimei plans to build multiple enzyme-based processing facilities across China during the 14th Five-Year Plan, aiming to process nearly 10 million tons of straw annually and expand its technology to regions rich in straw resources globally [13][15]. - The company aims to contribute to sustainable development by transforming straw from a burden into a valuable resource, showcasing the potential of new production capabilities in traditional agriculture [15].

Core Insights - Shenzhen Zhongnong Qimei Technology Co., Ltd. has signed strategic cooperation agreements with multiple governments and enterprises to promote the resource utilization of straw, marking a significant transition from the initial development phase to large-scale replication [1][2] - The company’s proprietary technology can convert 100% of straw from nine major crops into high-value products, achieving a 70% reduction in energy consumption and an 80% reduction in water usage compared to traditional chemical methods [2][3] - The collaboration aims to integrate resources from government, enterprises, and research institutions, facilitating a shift from policy-driven to market-driven development in the straw resource utilization industry [3] Company Developments - The signing of strategic cooperation agreements is a milestone for Zhongnong Qimei, indicating a move towards large-scale industrial promotion and the establishment of a closed-loop industrial chain for straw resource utilization [2][3] - The company plans to establish multiple straw resource utilization projects nationwide, enhancing market-oriented and large-scale development [2] - The technology has already been successfully applied to produce environmentally friendly materials, showcasing its market potential [3] Industry Impact - The collaboration is expected to address long-standing challenges in agricultural waste management in China, providing new solutions for sustainable agricultural development [3] - The integration of artificial intelligence and synthetic biology is highlighted as a driving force for technological and industrial advancement, positioning these areas as strategic competitive advantages globally [2]

Core Viewpoint - The innovative enzyme-based technology developed by Zhongnong Qimei is transforming agricultural waste, specifically straw, into high-value products, addressing environmental concerns and economic inefficiencies associated with traditional straw disposal methods [1][3][4]. Technology and Innovation - Zhongnong Qimei's "three-component separation" technology effectively decomposes straw from nine major crops, achieving 100% conversion into high-value industrial products such as pulp fibers and soluble humic acid, thus realizing zero waste and low energy consumption [4][11]. - The company has established a robust patent protection network covering enzyme modification, production processes, and equipment, solidifying its competitive edge in the market [6]. Industrialization and Market Potential - A 20,000-ton raw material industrial demonstration line in Suzhou, Anhui, has been successfully operational, validating the technology's market and economic viability [3][7]. - The company plans to build a modular factory capable of processing 120,000 tons of straw, with an expected annual output of 72,000 tons of bio-based fiber products and 48,000 tons of soluble humic acid [7][10]. Environmental Benefits - The enzyme-based method eliminates the production of harmful black liquor associated with traditional chemical pulping, achieving nearly 100% straw utilization [11][13]. - This technology not only addresses domestic pulp shortages but also reduces reliance on imported wood pulp, which constituted nearly 50% of China's pulp consumption [11][13]. Future Development Plans - Zhongnong Qimei aims to establish multiple enzyme-based straw processing bases across the country during the 14th Five-Year Plan, targeting the processing of nearly 10 million tons of straw annually [10][13]. - The company is also looking to expand internationally by promoting high-fiber plant cultivation and establishing smart production bases in resource-rich areas [11][13].

Core Viewpoint - *ST Meigu's performance in the medical beauty sector shows strong revenue but declining profitability, indicating potential challenges ahead [2][3]. Group 1: Company Overview - *ST Meigu was established on June 8, 1993, and listed on the Shenzhen Stock Exchange on October 16, 1996, with its registered office in Hubei Province and operational office in Guangdong Province [1]. - The company operates in the medical beauty service sector and has a competitive position in the market [1]. - Its main business includes the production and sale of viscose fibers and real estate development, categorized under the beauty care - medical beauty - medical beauty services industry [1]. Group 2: Financial Performance - In Q3 2025, *ST Meigu reported an operating revenue of 722 million yuan, ranking first in the industry, consistent with the industry average and median [2]. - The revenue breakdown shows that medical beauty services contributed 277 million yuan (57.47%), bio-based fibers contributed 186 million yuan (38.54%), and other services contributed 19.27 million yuan (3.99%) [2]. - The net profit for the same period was -149 million yuan, also ranking first in the industry, aligning with the industry average and median [2]. Group 3: Financial Ratios - As of Q3 2025, *ST Meigu's debt-to-asset ratio was 102.72%, an increase from 88.02% in the same period last year, indicating rising debt pressure [3]. - The gross profit margin for Q3 2025 was 21.16%, down from 26.91% in the previous year, reflecting a decline in profitability [3]. Group 4: Executive Compensation - The chairman, Liu Tao, received a salary of 11,100 yuan in 2024, while the president, Fan Shijie, earned 1.5682 million yuan, an increase of 243,100 yuan from 2023 [4]. Group 5: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 9.77% to 35,000, while the average number of circulating A-shares held per account increased by 10.83% to 21,800 [5].

Group 1 - The core point of the article is that *ST Meigu (SZ 000615) announced its financial performance and business composition for the first half of 2025, highlighting significant revenue contributions from its medical beauty services and bio-based fibers [1] - In the first half of 2025, the revenue composition of *ST Meigu was as follows: medical beauty services accounted for 57.47%, bio-based fibers accounted for 38.54%, and other services accounted for 3.99% [1] - As of the report date, *ST Meigu's market capitalization was 2.7 billion yuan [1] Group 2 - The article also mentions a broader market context, indicating that the A-share market has surpassed 4000 points, marking a significant resurgence after a decade of stagnation, with technology leading the market's new "slow bull" trend [1]

Core Viewpoint - The article highlights the innovative approach of Zhongnong Qimei Technology Co., Ltd. in transforming agricultural straw utilization through advanced synthetic biology techniques, addressing the inefficiencies of traditional methods and aiming for sustainable agricultural development [1][2][7]. Group 1: Technology and Innovation - Zhongnong Qimei's "high activity composite enzyme + intelligent equipment + full-process technology" offers a comprehensive solution for the high-purity separation and high-value utilization of cellulose, hemicellulose, and lignin from agricultural straw [1][2]. - The company's innovative "high activity enzyme hydrolysis technology" has been recognized as internationally leading, achieving nearly 100% straw utilization with a 70% reduction in energy consumption and an 80% reduction in water consumption compared to traditional chemical methods [2][3]. - The technology is designed to address the complex characteristics of straw, utilizing self-developed high-performance enzymes and an integrated R&D system to enhance efficiency and adaptability [3][4]. Group 2: Market Potential and Economic Impact - The theoretical straw resource in China is 977 million tons, with a collection potential of 737 million tons, creating a significant market opportunity for products derived from straw [2]. - Zhongnong Qimei's products, including bio-based fibers and soluble humic acid, are positioned to meet the growing demand for sustainable materials, with production costs for bio-based paper pulp being over 30% lower than traditional chemical pulp [5][6]. - The company plans to establish multiple enzyme hydrolysis straw industrial bases across the country, aiming for a scalable and replicable business model that integrates technology, equipment, and standards [2][5]. Group 3: Environmental and Social Benefits - The approach taken by Zhongnong Qimei addresses agricultural pollution, soil health, and food security by industrializing straw return to the soil, thus reducing open burning and enhancing soil quality [7]. - The dual benefits of bio-based fibers and humic acid contribute to ecological restoration and agricultural productivity, providing a sustainable solution to the challenges faced by the agricultural sector [6][7]. - The company's strategy not only aims for profitability but also emphasizes sustainability and replicability, paving the way for new development pathways in agriculture, materials, and ecological industries [7].